• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管鳞状细胞癌(ESCC):基因组学和分子遗传学进展

Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics.

作者信息

Chen J, Kwong D L, Cao T, Hu Q, Zhang L, Ming X, Chen J, Fu L, Guan X

机构信息

Departments of Clinical Oncology, The University of Hong Kong, Hong Kong; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Dis Esophagus. 2015 Jan;28(1):84-9. doi: 10.1111/dote.12088. Epub 2013 Jun 24.

DOI:10.1111/dote.12088
PMID:23796192
Abstract

Esophageal cancer is aggressive and has poor prognosis. Esophageal squamous cell carcinoma (ESCC) is histologically the most prevalent type of esophageal cancer and ranked as the sixth leading cause of cancer death worldwide. In recent years, cancer has been widely regarded as genetic disease, as well as epigenetic abnormalities including DNA methylation, histone deacetylation, chromatin remodeling, gene imprinting and noncoding RNA regulation. In this review, we will provide a general overview of genes, proteins and microRNAs that are involved in the development of ESCC, which aims to enhance our understanding of molecular mechanisms implicated in ESCC development and progression.

摘要

食管癌具有侵袭性,预后较差。食管鳞状细胞癌(ESCC)在组织学上是食管癌最常见的类型,是全球癌症死亡的第六大主要原因。近年来,癌症已被广泛视为一种遗传疾病,以及包括DNA甲基化、组蛋白去乙酰化、染色质重塑、基因印记和非编码RNA调控在内的表观遗传异常。在本综述中,我们将概述参与ESCC发生发展的基因、蛋白质和微小RNA,旨在加深我们对ESCC发生发展和进展所涉及分子机制的理解。

相似文献

1
Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics.食管鳞状细胞癌(ESCC):基因组学和分子遗传学进展
Dis Esophagus. 2015 Jan;28(1):84-9. doi: 10.1111/dote.12088. Epub 2013 Jun 24.
2
DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.DNMT1- microRNA126 表观遗传回路通过 ADAM9- EGFR-AKT 信号通路促进食管鳞癌细胞生长。
Clin Cancer Res. 2015 Feb 15;21(4):854-63. doi: 10.1158/1078-0432.CCR-14-1740. Epub 2014 Dec 15.
3
Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.食管鳞状细胞癌中的表观遗传改变及其临床意义
Gen Thorac Cardiovasc Surg. 2013 May;61(5):262-9. doi: 10.1007/s11748-013-0235-3. Epub 2013 Mar 26.
4
Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma.Igf2 启动子的表观遗传改变及 miR-483-5p 对食管鳞癌细胞中其靶基因表达的影响。
Mol Med Rep. 2018 Feb;17(2):2251-2256. doi: 10.3892/mmr.2017.8134. Epub 2017 Nov 22.
5
Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.食管鳞状细胞癌中与淋巴结转移相关的DNA甲基化全基因组筛查。
Oncotarget. 2017 Jun 6;8(23):37740-37750. doi: 10.18632/oncotarget.17147.
6
The global expression profiling in esophageal squamous cell carcinoma.食管鳞状细胞癌中的全基因组表达谱分析。
Genomics. 2017 Jul;109(3-4):241-250. doi: 10.1016/j.ygeno.2017.04.005. Epub 2017 Apr 22.
7
Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma.非编码RNA表达异常与癌症进展相关,是食管鳞状细胞癌的潜在生物标志物。
Int J Mol Sci. 2015 Nov 24;16(11):27824-34. doi: 10.3390/ijms161126060.
8
The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.DNA甲基化在人食管鳞状细胞癌中的诊断、预后及预测价值。
Clin Epigenetics. 2016 Apr 22;8:43. doi: 10.1186/s13148-016-0210-9. eCollection 2016.
9
An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinoma.微小RNA和信使核糖核酸对食管鳞状细胞癌影响的综合分析
Mol Med Rep. 2015 Jul;12(1):945-52. doi: 10.3892/mmr.2015.3557. Epub 2015 Mar 27.
10
Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.食管鳞状细胞癌基因表达谱的生物信息学分析
Dis Esophagus. 2017 May 1;30(5):1-8. doi: 10.1093/dote/dow018.

引用本文的文献

1
Real-World Clinical Outcomes of Trilaciclib for the Prevention of Myelosuppression in Patients with Esophageal Cancer Undergoing Chemotherapy.曲拉西利预防接受化疗的食管癌患者骨髓抑制的真实世界临床结局
Curr Oncol. 2025 Mar 24;32(4):189. doi: 10.3390/curroncol32040189.
2
Effects of FAP+ fibroblasts on cell proliferation migration and immunoregulation of esophageal squamous carcinoma cells through the CXCL12/CXCR4 axis.FAP+成纤维细胞通过CXCL12/CXCR4轴对食管鳞状癌细胞增殖、迁移及免疫调节的影响
Mol Cell Biochem. 2025 Jun;480(6):3841-3855. doi: 10.1007/s11010-025-05226-x. Epub 2025 Feb 11.
3
Digestive cancers: mechanisms, therapeutics and management.
消化系统癌症:机制、治疗方法与管理
Signal Transduct Target Ther. 2025 Jan 15;10(1):24. doi: 10.1038/s41392-024-02097-4.
4
Advanced esophageal cancer with bone metastases: Prognostic biomarkers and palliative treatment.伴有骨转移的晚期食管癌:预后生物标志物与姑息治疗
Heliyon. 2023 Dec 9;10(1):e23510. doi: 10.1016/j.heliyon.2023.e23510. eCollection 2024 Jan 15.
5
LncRNA FTH1P3: A New Biomarker for Cancer-Related Therapeutic Development.长链非编码RNA FTH1P3:癌症相关治疗开发的新生物标志物。
Curr Mol Med. 2024;24(5):576-584. doi: 10.2174/1566524023666230724141353.
6
Frequency of HER2 Expression, MMR Deficiency, and PI3KCA Mutation in Pretreated Surgical Specimens of Patients with Esophageal Squamous Cell Carcinoma in Iran Cancer Institute.伊朗癌症研究所食管鳞状细胞癌患者预处理手术标本中HER2表达频率、错配修复缺陷及PI3KCA突变情况
Iran J Pathol. 2023;18(1):96-103. doi: 10.30699/IJP.2023.563358.2989. Epub 2023 Mar 23.
7
Targeting PP2A for cancer therapeutic modulation.针对癌症治疗调节的 PP2A 靶向治疗。
Cancer Biol Med. 2022 Nov 1;19(10):1428-39. doi: 10.20892/j.issn.2095-3941.2022.0330.
8
Investigation on the Potential Correlation Between and Esophageal Cancer.[具体内容]与食管癌之间潜在相关性的研究。 需注意,原文中“Investigation on the Potential Correlation Between and Esophageal Cancer.”存在信息缺失,“Between”后面缺少具体内容。以上译文是根据补充完整后的假设进行翻译的示例,实际翻译时请根据准确原文进行。
Front Cell Dev Biol. 2021 Oct 27;9:730337. doi: 10.3389/fcell.2021.730337. eCollection 2021.
9
Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma.食管鳞癌联合治疗获得性耐药的基因组和表观基因组进化。
JCI Insight. 2021 Sep 8;6(17):e150203. doi: 10.1172/jci.insight.150203.
10
LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis.LINC00667 通过调控 miR-200b-3p/SLC2A3 轴促进食管癌细胞的进展。
Dig Dis Sci. 2022 Jul;67(7):2936-2947. doi: 10.1007/s10620-021-07145-5. Epub 2021 Jul 27.